InVivo Therapeutics Holdings Corp logo

NVIV

NASDAQ

InVivo Therapeutics Holdings Corp

SectorHealth CareIndustryBiotechnology: Biological Products (No Diagnostic Substances)
$0.32-0.17 (-34.04%)
Website
News25/Ratings0

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. InVivo Therapeutics Holdings Corp. was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.

Latest news

25 items